Risk Factors for Preeclamsia
DOI:
https://doi.org/10.70062/greenhealth.v2i3.204Keywords:
Determining factors, Hypertension, Maternal riskPreeclampsia, PregnancyAbstract
Preeclampsia is a severe pregnancy complication characterized by hypertension and signs of organ damage, with a multifactorial etiology involving maternal, genetic, and environmental interactions. This study aims to analyze determinants contributing to the occurrence of preeclampsia through a comprehensive literature review. The research method involved an in-depth analysis of 15 scientific journals, consisting of 8 national publications from Google Scholar and 7 international publications from PubMed, selected based on relevance, credibility, and publication date. Data from these sources were synthesized to identify common risk factors, biological mechanisms, and preventive measures. The findings indicate that the primary risk factors for preeclampsia include a history of chronic hypertension, obesity, gestational diabetes, nulliparity (first pregnancy), and a family history of preeclampsia. Nutritional deficiencies, particularly low calcium and vitamin D intake, are also significantly associated with increased risk. Furthermore, immunological factors such as abnormal maternal immune tolerance, as well as placental dysfunction leading to poor perfusion, play a crucial role in the pathogenesis of preeclampsia. The interplay between these factors suggests that preeclampsia is not caused by a single mechanism, but rather by a complex network of physiological, metabolic, and genetic influences. This complexity underscores the importance of early risk factor identification and intervention strategies during antenatal care. Preventive efforts may include nutritional supplementation, weight management, blood pressure monitoring, and targeted medical interventions for high-risk individuals. In conclusion, preeclampsia remains a significant contributor to maternal and perinatal morbidity and mortality worldwide. Understanding its determinants enables healthcare providers to implement timely preventive measures and reduce its negative impacts on both mother and fetus. Further research is warranted to elucidate the precise mechanisms underlying these determinants, potentially paving the way for more effective prevention and treatment strategies.
References
ACOG. (2020). Gestational hypertension and preeclampsia: ACOG practice bulletin No. 222. Obstetrics & Gynecology, 135(6), e237–e260. https://doi.org/10.1097/AOG.0000000000003891
Anggraeni, D., & Saputra, E. (2021). Disfungsi plasenta dan biomarker angiogenik pada preeklampsia. Jurnal Penelitian Medika, 25(1), 56–64.
Brown, M. A., Magee, L. A., Kenny, L. C., & Roberts, J. M. (2022). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations. Pregnancy Hypertension, 28, 1–25. https://doi.org/10.1016/j.preghy.2022.01.002
Dewi, N. K., & Setiawan, B. (2021). Pengaruh riwayat hipertensi kronis terhadap preeklampsia di Jawa Barat. Jurnal Kesehatan Masyarakat Nasional, 16(2), 89–97.
Fitriani, R., & Sari, D. P. (2021). Hubungan obesitas dan kejadian preeklampsia di RSUD Jakarta. Jurnal Kesehatan Ibu dan Anak, 15(2), 45–53.
Handayani, L., & Susanto, H. (2022). Defisiensi vitamin D sebagai prediktor preeklampsia di wilayah urban. Jurnal Obstetri dan Ginekologi Indonesia, 44(1), 30–38.
Kusuma, A., & Rahman, F. (2022). Peran asupan kalsium dalam pencegahan preeklampsia. Jurnal Gizi Klinik Indonesia, 18(1), 34–42.
Lisonkova, S., Joseph, K. S., & Magee, L. A. (2021). Temporal trends in preeclampsia incidence and outcomes: A population-based study. JAMA Network Open, 4(2), e2037889. https://doi.org/10.1001/jamanetworkopen.2020.37889
Novianti, R., & Hidayat, T. (2023). Perbandingan risiko preeklampsia pada kehamilan pertama dan berulang. Jurnal Ilmu Kedokteran, 17(2), 112–120.
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2020). Pre-eclampsia: Pathogenesis, novel diagnostics, and therapies. Nature Reviews Nephrology, 16(5), 275–290. https://doi.org/10.1038/s41581-020-0276-6
Purwanti, E., & Wijaya, A. (2023). Analisis faktor genetik (polimorfisme VEGF) pada preeklampsia. Jurnal Biomedik dan Kesehatan, 16(1), 67–75.
Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2021). Preeclampsia: Pathophysiology and clinical management. The New England Journal of Medicine, 384(9), 841–852. https://doi.org/10.1056/NEJMra2022236
Rolnik, D. L., Wright, D., Poon, L. C., & Nicolaides, K. H. (2021). ASPRE trial: Performance of screening for preeclampsia. Ultrasound in Obstetrics & Gynecology, 57(1), 89–99. https://doi.org/10.1002/uog.21900
Turbeville, H. R., & Sasser, J. M. (2020). Preeclampsia beyond pregnancy: Long-term consequences for mother and child. American Journal of Physiology-Renal Physiology, 318(6), F1315–F1326. https://doi.org/10.1152/ajprenal.00110.2020
Wahyuni, S., & Prasetyo, B. (2020). Faktor risiko preeklampsia pada ibu hamil di Indonesia: Studi kasus kontrol. Jurnal Kebidanan Indonesia, 11(3), 112–120.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Green Health International Journal of Health Sciences Nursing and Nutrition

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

